microRNA information: hsa-miR-190a-5p

SectionIDlink
Mature name: hsa-miR-190a-5pmiRbase
Accession: MIMAT0000458miRbase
Precursor name: hsa-mir-190a miRbase
Precursor accession: MI0000486miRbase
Symbol: NAHGNC
RefSeq ID: NAGenBank
Sequence: UGAUAUGUUUGAUAUAUUAGGU



Reported expression in cancers: hsa-miR-190a-5p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-190a-5p

liver cancerupregulation"Increased expression of miR-190 may cause decrease ......"24586785
hsa-miR-190a-5p

pancreatic cancerupregulation"Profiling of 95 microRNAs in pancreatic cancer cel ......"19030927qPCR



Reported cancer pathway affected by hsa-miR-190a-5p

miRNAcancerpathwayreportingPUBMEDfunctional study



Reported cancer prognosis affected by hsa-miR-190a-5p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-190a-5p

breast cancermetastasis; cell migration; drug resistance; staging; tumorigenesis; poor survival"SNPs tagging the 15q22.2 locus showed a significan ......"24009311
hsa-miR-190a-5p

breast cancerdrug resistance"Among these miRNAs we identified-miR-200b-3p miR-1 ......"24469723
hsa-miR-190a-5p

prostate cancermetastasis; poor survival; staging"MiR-190a belongs to the small noncoding RNA family ......"26314494



Reported gene related to hsa-miR-190a-5p

miRNAcancergenereportingPUBMED
hsa-miR-190a-5p

prostate cancerAR"Reduced expression of miR-190a was inversely corre ......"26314494
hsa-miR-190a-5p

breast cancerESR1"In addition the promoter region of miR-190a was de ......"24009311
hsa-miR-190a-5p

gastric cancerFOXP2"To investigate how microRNA-190 miR-190 regulates ......"27382302
hsa-miR-190a-5p

prostate cancerYBX1"Taken together our findings identified a biochemic ......"26314494



Expression profile in cancer corhorts:




Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-190a-5p
BACH2
9 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LGG; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.252; TCGA COAD -0.382; TCGA ESCA -0.326; TCGA KIRC -0.177; TCGA KIRP -0.196; TCGA LGG -0.101; TCGA THCA -0.243; TCGA STAD -0.414; TCGA UCEC -0.307
hsa-miR-190a-5p
IL1RAP
9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PRAD; THCA
MirTarget
TCGA BLCA -0.193; TCGA CESC -0.144; TCGA ESCA -0.389; TCGA HNSC -0.103; TCGA KIRC -0.265; TCGA KIRP -0.322; TCGA LUSC -0.202; TCGA PRAD -0.091; TCGA THCA -0.598
hsa-miR-190a-5p
ACTG1
9 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; LUAD; LUSC; THCA; UCEC
MirTarget
TCGA BLCA -0.072; TCGA BRCA -0.086; TCGA KIRC -0.098; TCGA KIRP -0.069; TCGA LIHC -0.065; TCGA LUAD -0.105; TCGA LUSC -0.089; TCGA THCA -0.103; TCGA UCEC -0.093
hsa-miR-190a-5p
F2R
9 cancers: BLCA; BRCA; COAD; LGG; PAAD; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.154; TCGA BRCA -0.09; TCGA COAD -0.233; TCGA LGG -0.209; TCGA PAAD -0.227; TCGA PRAD -0.12; TCGA THCA -0.103; TCGA STAD -0.119; TCGA UCEC -0.179
hsa-miR-190a-5p
SEC23A
9 cancers: BLCA; ESCA; KIRC; LUSC; PRAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.151; TCGA ESCA -0.081; TCGA KIRC -0.094; TCGA LUSC -0.103; TCGA PRAD -0.122; TCGA SARC -0.122; TCGA THCA -0.184; TCGA STAD -0.172; TCGA UCEC -0.099
hsa-miR-190a-5p
DRP2
11 cancers: BRCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BRCA -0.18; TCGA CESC -0.213; TCGA ESCA -0.403; TCGA LGG -0.237; TCGA LUAD -0.257; TCGA LUSC -0.423; TCGA PAAD -0.316; TCGA PRAD -0.13; TCGA SARC -0.219; TCGA STAD -0.753; TCGA UCEC -0.257
hsa-miR-190a-5p
ASAP1
9 cancers: COAD; ESCA; HNSC; KIRC; KIRP; PAAD; PRAD; THCA; STAD
MirTarget
TCGA COAD -0.155; TCGA ESCA -0.153; TCGA HNSC -0.06; TCGA KIRC -0.146; TCGA KIRP -0.138; TCGA PAAD -0.116; TCGA PRAD -0.084; TCGA THCA -0.083; TCGA STAD -0.213
hsa-miR-190a-5p
PFDN4
9 cancers: ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; THCA; STAD
MirTarget
TCGA ESCA -0.076; TCGA KIRC -0.138; TCGA KIRP -0.106; TCGA LGG -0.051; TCGA LIHC -0.118; TCGA LUSC -0.128; TCGA PRAD -0.072; TCGA THCA -0.097; TCGA STAD -0.101





Enriched cancer pathways of putative targets